Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
7. Last week PR.
I'd like to see them become SEC current.
There was 300k on the bid yesterday if one so chooses ;)
Releasing anything related to COVID is dangerous with the SEC, especially for a microcap stock. They clearly were going for a pump but market isn't budging.
.04's and mid to high .03's should hold for some time. That puts us where we were before the corona pump.
We'll see. No one here knows what's really going on so just banter. I will say though the former CEO was working on all this extra paperwork for the S1 filing then up and left on her own terms. Interesting to ponder what really went down.
It was already delayed, then the CEO left. So yeah, I'd say common sense would dictate it's going to be some time until we something related to it.
I would hope shareholders, or potential shareholders that have critical thinking skills could understand that any uplisting work is probably on the back burner now as the company only has an interim CEO. Who do they think is working on this deal now?
Give it a rest and come to grips that any S1 filing has been delayed. That doesn't mean it isn't coming but you're doing more harm than good by still saying that it's "imminent". Patience.
Edit: And on the notion that someone will inevitably say "Well yeah but they said very very soon on the conference call." Well...what do you expect them to say? "oh by the way,due to Mars leaving the S1 is going to be another 3-6 months pushed back." Really?
P A T I E N C E
How long until a product usually hits peak revenues? There's (possibly) your answer.
You'd be surprised then. They know about IHUB. Jerry Treppel years ago made some funny remarks about it.
Also important to note that Nasrats recent conversion of preferred shares to common shares was at .15 a share.
The same guy is also banned from FINRA for running IPO scams on uninformed investors stating huge gains were coming.
RXMD has a ton of potential but just remember where these words are coming for.
The only connection was rumors on a public message board. The company itself never said a word about it.
Truth is no one knows when, or if it will happen. Saying "soon" is doing more harm than good because when "soon" passes, people get disappointed, assume something is wrong and then sell. So, how about we just say "no one knows" when any uplisting might occur.
As I said before, the former CEO isn't around anymore who was going to be the foundation for the S1. So it's safe to assume there is going to be another delay because of that. Only makes sense.
I rather enjoyed the argument that Elite's CEO, the guy who owns 260 million common shares...who would benefit more than anyone with the shareprice rising..."gave away" and "screwed shareholders"(himself, btw) by selling off these "$100 million revenue drugs". Ohhh but "Nasrat helped his pharma bros at Nostrum by giving them these $100 million/revenue products". Wow thats a nice friend to give away that kind of money when you own 26% of the company that used to own them!
Oh well. Next.
It's hard to really deny there are some shady people connected to this company. Not saying the company isn't legit (I think it is) but there's no way in hell they are uplisting to the Nasdaq, getting funds to invest in them when you have these guys running the company. No way.
I second this. It would ease a lot of peoples minds. Plus, why not?
nice 3 million bid at .04
Just keeping it real here but I fail to see how the investment community will get being RXMD if they make it to the Nasdaq when people find out the guy calling the shots (Armen) was barred from FINRA for running pump and dump IPO scams.
He's gotta go before any uplisting.
My question still is: For $10 million there isn't something that would add more value to the company quicker?
Armen is banned from FINRA for doing IPO scams to unaware investors promising huge returns. Sure, people can change their ways but we can't have him anywhere near a company that is going to uplist to the Nasdaq, imo.
Not an expert in the field, so I'll say that upfront. But for $10 million my first thought was surely there's something better they could've spent that kind of money on to get more revenue in the door quicker.
I could be wrong but off base here but just my first thought.
There will be more bid hitting come Monday. Have your orders ready if you choose. :)
That person was/is most definitely selling at whatever price they can.
This, + the person looks to still have at least 1.5 million to sell.
1.7 mill on ask from ETRF at .035
Low, mid .04 range seems to be a good support level to add to if one so chooses.
If RXMD uplists, it won't be with the RXMD name. It will be with another company. As stated before, the history isn't great with companies that filed a 15-12G then went on to uplist.
The now former CEO basically said not too long ago that the process will take a lot longer as the work basically doubled. Now factor in a new acting CEO and add more time on top. Why some people are acting like the news will be released tomorrow I have no clue. All talking like that is doing is getting new investors discouraged when days go by and no news of it occurring happens. Give it time.
Hey, as long as the share price gets going higher, I'm all for carrot dangling. :)
A reputable company trying to get on the Nasdaq shouldn't have a business relationship with someone with that history.
RXMD should go a separate way.
I must say that is pretty surprising that they would let him near a publicly traded company with that record. Not a great look imo.
Edit: And he was busted for saying companies were going to do an IPO. Sounds kinda familiar.
At 7 cents, or a 65 million market cap I have to agree. There's just too much upside vs the limited downside when the company is already profitable.
CEO has 260 million common shares. Seems like a good thing. Could he be wrong? Sure but I'll follow the money.
You just claimed the stock has done "nothing" the whole time; I corrected your error.
The correct thing would have been to say the stock has basically done nothing for ~3 years.
Wrong, stock ran from .07 to .97 within 1 year of him being the CEO; it then went down to low .20's before making a run to .37 the year later. Is now at a basement price in the .07's gearing up for a run.
Not everyone has waited 7 years. That's investing.
Waiting = Investing
Maybe, time will tell. That's why I always scale in. Way more on the positive vs negative side here long term. Good luck.
There are many on the same site that say they like Lannett's over Teva.